BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11007163)

  • 21. [Genomic instability associated with human LINE-1 rétrotransposition].
    Gilbert N; Doucet AJ; Bucheton A
    J Soc Biol; 2004; 198(4):419-24. PubMed ID: 15969349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Interspersed Nuclear Elements 1 (LINE1): The chimeric transcript L1-MET and its involvement in cancer.
    Cervantes-Ayalc A; Ruiz Esparza-Garrido R; Velázquez-Flores MÁ
    Cancer Genet; 2020 Feb; 241():1-11. PubMed ID: 31918342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection.
    Liu ZJ; Huang Y; Wei L; He JY; Liu QY; Yu XQ; Li ZL; Zhang J; Li B; Sun CJ; Liang WB; Sun AM; Qin Y
    Neoplasma; 2017; 64(5):795-802. PubMed ID: 28592132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINE-1 Evasion of Epigenetic Repression in Humans.
    Sanchez-Luque FJ; Kempen MHC; Gerdes P; Vargas-Landin DB; Richardson SR; Troskie RL; Jesuadian JS; Cheetham SW; Carreira PE; Salvador-Palomeque C; García-Cañadas M; Muñoz-Lopez M; Sanchez L; Lundberg M; Macia A; Heras SR; Brennan PM; Lister R; Garcia-Perez JL; Ewing AD; Faulkner GJ
    Mol Cell; 2019 Aug; 75(3):590-604.e12. PubMed ID: 31230816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the extent of LINE-1 mobility following exposure to heavy metals in HepG2 cells.
    Karimi A; Madjd Z; Habibi L; Akrami SM
    Biol Trace Elem Res; 2014 Jul; 160(1):143-51. PubMed ID: 24894828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma.
    Dammann RH; Kirsch S; Schagdarsurengin U; Dansranjavin T; Gradhand E; Schmitt WD; Hauptmann S
    Int J Oncol; 2010 Jan; 36(1):171-9. PubMed ID: 19956846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
    Yang B; Guo M; Herman JG; Clark DP
    Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma.
    Tangkijvanich P; Hourpai N; Rattanatanyong P; Wisedopas N; Mahachai V; Mutirangura A
    Clin Chim Acta; 2007 Apr; 379(1-2):127-33. PubMed ID: 17303099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma.
    Couvert P; Carrié A; Pariès J; Vaysse J; Miroglio A; Kerjean A; Nahon P; Chelly J; Trinchet JC; Beaugrand M; Ganne-Carrié N
    World J Gastroenterol; 2008 Sep; 14(35):5419-27. PubMed ID: 18803353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.
    Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
    Hepatology; 2001 Mar; 33(3):561-8. PubMed ID: 11230735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypomethylation of the c-myc oncogene in liver cirrhosis and chronic hepatitis.
    Aiba N; Nambu S; Inoue K; Sasaki H
    Gastroenterol Jpn; 1989 Jun; 24(3):270-6. PubMed ID: 2545502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methylation pattern of DNA repair genes and microsatellite instability in hepatocelluar carcinoma].
    Park JH; Cho SB; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS; Lee JH; Kim SJ
    Korean J Gastroenterol; 2006 Nov; 48(5):327-36. PubMed ID: 17132921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinoma.
    Couvert P; Carrié A; Tezenas du Montcel S; Vaysse J; Sutton A; Barget N; Trinchet JC; Beaugrand M; Ganne N; Giral P; Chelly J
    Clin Res Hepatol Gastroenterol; 2012 Aug; 36(4):345-51. PubMed ID: 22902352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
    Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Methylation status of c-fms oncogene in hepatocellular carcinoma and its relation with clinical pathology].
    Cui J; Yang D
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):137-8. PubMed ID: 11412385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma.
    Lee YR; Kim G; Lee HW; Tak WY; Park SY; Jang SY; Kweon YO; Park JG; Han YS; Chun JM; Han JR; Hur K
    Medicine (Baltimore); 2021 Apr; 100(16):e25552. PubMed ID: 33879706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma.
    Zhang C; Xu Y; Zhao J; Fan L; Jiang G; Li R; Ling Y; Wu M; Wei L
    Ann Surg Oncol; 2011 Aug; 18(8):2373-80. PubMed ID: 21331808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.